Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
American Journal of Clinical Pathology|October 1, 1976
Significance of anti-HBc in patients with hepatic disease. A comparative immunohistochemical study of blood and hepatic tissueL Kater, A J VogtenThe Netherlands Journal of Medicine|February 1, 1990
Campylobacter jejuni: clinical and diagnostic value of serum antibody titresJ J Kolkman, A J VogtenGut|June 1, 1979
HLA and cell-mediated immunity in HBsAg negative chronic active hepatitisA J Vogten, R G Shorter, G OpelzThe Netherlands Journal of Medicine|April 1, 1992
Estimation of survival probability in cirrhotics. Evaluation of a computer model applicable for decision-makingA M Schrander-van der Meer, A J VogtenDigestion|January 1, 1982
Clinical evaluation of the liver cell membrane autoantibody assayH J Schuurman, A J Vogten, S W Schalm, et al.Gastroenterology|May 1, 1978
Cell-mediated cytotoxicity in chronic active liver disease: a new test systemA J Vogten, N Hadzic, R G Shorter, et al.Tissue Antigens|January 1, 1977
HLA determinants in chronic active liver disease: possible relation of HLA-Dw3 to prognosisG Opelz, A J Vogten, W H Summerskill, et al.American Journal of Clinical Pathology|January 1, 1979
Alcoholic hepatic disease. Specificity of IgA deposits in liverL Kater, A C Jöbsis, E H de la Faille-Kuyper, et al.Lancet (London, England)|July 17, 1976
Behaviour of e antigen and antibody during chronic active liver disease. Relation to HB antigen-antibody system and prognosisA J Vogten, W H Summerskill, G L Gitnick, et al.Alimentary Pharmacology & Therapeutics|October 1, 1989
Omeprazole (20 mg o.m.) versus ranitidine (150 mg b.d.) in duodenal ulcer healing and pain reliefC J Mulder, G N Tijtgat, O J Cluysenaer, et al.Pageof 1